Skip to content

Released Aug 11, 2015, before the open

10-Q filed Aug 11, 2015, 42 days after period end · 0001144204-15-047956

Q2 2015 · 10-Q
Revenue—
Net Income-$4.25MN/M vs Q2 2014N/M vs Q1 2015
EPS Diluted-$0.26N/M vs Q2 2014N/M vs Q1 2015
Operating Income-$4,277,743N/M
Operating Cash Flowderived-$3,861,542N/M
Free Cash Flowderived-$3,863,091N/M

What the release said

The release

Same quarter

MetricQ2 2015Q2 2014Q2 2013Q2 2012
Net Income-$4.25M-$6.97M-$1.37M-$61.23K
EPS Diluted-$0.26-$0.55-$0.31—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR